Danaher Corporation

Symbol: DHR     Sector: Healthcare     Industry: Medical Diagnostics & Research

Dividend Yield
0.48%
Current Price
$140.44
Info     Dividend Rate History     Earnings     Financials     Rankings

Financials 2019

Update: 2019-06-10 11:40:01

Period

Report Date
Operating Revenue
Total Revenue
Cost of Revenue
Gross Profit
Operating Expense
Operating Income
Net Income
Current Assets
Total Assets
Total Liabilities
Shareholders Equity
Current Cash
Current Debt
Total Cash
Total Debt
Cash Change
Cash Flow
 
R&D

Q 1

2019-03-31
4,879,900,000
4,879,900,000
2,161,900,000
2,718,000,000
1,994,200,000
723,800,000
333,800,000
10,080,400,000
51,774,400,000
20,205,700,000
31,556,600,000
3,910,000,000
36,600,000
3,910,000,000
9,494,800,000
3,082,600,000
703,300,000
 
310,800,000

Financials 2018

Update: 2019-06-10 11:40:01

Period

Report Date
Operating Revenue
Total Revenue
Cost of Revenue
Gross Profit
Operating Expense
Operating Income
Net Income
Current Assets
Total Assets
Total Liabilities
Shareholders Equity
Current Cash
Current Debt
Total Cash
Total Debt
Cash Change
Cash Flow
 
R&D

Q 4

2018-12-31
5,363,500,000
5,363,500,000
2,407,600,000
2,955,900,000
1,993,300,000
962,600,000
746,800,000
7,093,800,000
47,832,500,000
19,605,800,000
28,214,400,000
787,800,000
51,800,000
787,800,000
9,740,300,000
25,100,000
1,237,600,000
 
319,600,000

Q 3

2018-09-30
4,853,100,000
4,853,100,000
2,162,600,000
2,690,500,000
1,859,800,000
830,700,000
663,700,000
6,830,500,000
47,719,500,000
20,034,300,000
27,673,400,000
776,200,000
59,800,000
776,200,000
10,617,800,000
-99,900,000
919,500,000
 
301,200,000

Q 2

2018-06-30
4,981,000,000
4,981,000,000
2,163,900,000
2,817,100,000
1,949,600,000
867,500,000
673,800,000
6,913,100,000
48,055,800,000
20,831,400,000
27,212,300,000
904,000,000
175,100,000
904,000,000
11,320,700,000
-34,500,000
1,036,000,000
 
311,700,000

Q 1

2018-03-31
4,695,400,000
4,695,400,000
2,051,800,000
2,643,600,000
1,900,600,000
743,000,000
566,600,000
7,075,100,000
47,145,200,000
19,943,400,000
27,189,900,000
1,045,700,000
98,700,000
1,045,700,000
10,509,400,000
384,500,000
828,900,000
 
298,700,000

Financials 2017

Update: 2019-06-10 11:40:01

Period

Report Date
Operating Revenue
Total Revenue
Cost of Revenue
Gross Profit
Operating Expense
Operating Income
Net Income
Current Assets
Total Assets
Total Liabilities
Shareholders Equity
Current Cash
Current Debt
Total Cash
Total Debt
Cash Change
Cash Flow
 
R&D

Q 4

2017-12-31
5,085,700,000
5,085,700,000
2,246,600,000
2,839,100,000
1,870,800,000
968,300,000
856,600,000
6,850,000,000
46,648,600,000
20,280,800,000
26,358,200,000
630,300,000
194,700,000
630,300,000
10,522,100,000
-34,700,000
834,700,000
 
298,900,000